SL Bigen Overview
- Status
-
Private
- Latest Deal Type
-
Seed
- Investors
-
3
SL Bigen General Information
Description
Developer of bio-genetic drugs designed to focus on cell-based therapies by developing innovative biologics. The company specializes in developing mesenchymal stem cell lines and natural killer cells targeting cancer and neurodegenerative diseases, enabling healthcare providers to save patients' lives through advanced cellular therapies.
Contact Information
Website
www.slbigen.comCorporate Office
- SL BIGEN Research Hall
- 85, Songdo gwahak-ro, Yeonsu-gu
- Incheon
- South Korea
Corporate Office
- SL BIGEN Research Hall
- 85, Songdo gwahak-ro, Yeonsu-gu
- Incheon
- South Korea
SL Bigen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Seed Round | 01-Jun-2025 | Completed | Clinical Trials - Phase 2 | |||
| 1. Corporate | 19-Nov-2019 | Completed | Startup |
SL Bigen Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Innopolis Partners | Venture Capital | Minority | ||
| Winvest Venture Capital | Venture Capital | Minority | ||
| Yuhan | Corporation | Minority |
SL Bigen FAQs
-
Where is SL Bigen headquartered?
SL Bigen is headquartered in Incheon, South Korea.
-
What industry is SL Bigen in?
SL Bigen’s primary industry is Drug Discovery.
-
Is SL Bigen a private or public company?
SL Bigen is a Private company.
-
What is SL Bigen’s current revenue?
The current revenue for SL Bigen is .
-
How much funding has SL Bigen raised over time?
SL Bigen has raised $2.6M.
-
Who are SL Bigen’s investors?
Innopolis Partners, Winvest Venture Capital, and Yuhan have invested in SL Bigen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process